Category Archives: Innovation

Transparency and delinkage embedded into draft UN Political Declaration on Universal Health Coverage

Source: Keionline 5th August, 2019   UPDATE: On 29 July 2019, the co-facilitators (Ambassadors of Georgia and Thailand) of the intergovernmental consultations on a UN political declaration on universal health coverage announced that the silence procedure was broken by “several delegations … Continue reading

Posted in Delinkage, Transparency, Universal Health Coverage | Leave a comment

“Delinkage” Of Medicines R&D From Patent Incentives Stirs Debate at Human Rights Council

Source: Health Policy Watch 9th July, 2019   Only a month after a hotly-contested World Health Assembly resolution touched off a debate around “price transparency” as a way to improve access to medicines, a new controversy over how to stimulate access has emerged … Continue reading

Posted in Delinkage, Patent, R&D, Uncategorized | Leave a comment

DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases

Source: Health Policy Watch 19th April, 2019   Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Atomwise, Inc., a biotech company … Continue reading

Posted in Drugs, Innovation, Neglected Diseases, R&D | Leave a comment

State slow to switch to cheaper off-patent drugs, forum hears

Source: Irish Times 17th April, 2019   Health service could save €50m by using biosimilar medicines, says Michael Barry Prof Michael Barry has told a conference the pricing structures of pharmaceutical companies are unsustainable. Photograph: PA Wire Just six patients … Continue reading

Posted in Access to Medicins, Biologics/Biosimilars, Drug prices, Off Patent, orphan drug | Leave a comment

Evidence Shows Ring Vaccination Strategy Effective In Limiting Ebola Outbreak In DRC

Sources: Health Policy Watch 16th April, 2019   A preliminary analysis of the World Health Organization’s “ring vaccination” strategy against Ebola shows that vaccinating people who came into contact with Ebola patients is proving to be effective at preventing new … Continue reading

Posted in Ebola, Innovation, Vaccines, WHO | Leave a comment

Time to put a stop to the abuse of orphan drug regulation- the latest scandal

10th Jan 2019, New Delhi Source: Medicines Law and Policy Today, the Dutch Medical Journal (Nederlands Tijdschrift voor Geneeskunde) reported on the case of lutetium-octreotaat, a cancer drug developed by researchers in the Dutch Erasmus medical centre in Rotterdam. For … Continue reading

Posted in Access to Medecines, Cancer, Innovation, orphan drug, Patent, Price hikes, Pricing | Leave a comment

Indian Civil Society letter on TB Declaration negotiations -UN High Level Meeting

To, Mr. Narendra Modi, Prime Minister of India Mr. J. P. Nadda, Health Minister Ms. Sushma Swaraj, Foreign Minister Mr. Suresh Prabhu, Commerce Minister Date: 31st July 2018 Sub: Asking India to support TRIPS flexibilities in UN High Level Meeting on TB … Continue reading

Posted in Access to Medecines, Delinkage, R&D, TRIPS, TRIPS flexibilities, Tuberculosis (TB), Uncategorized | Leave a comment